Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Can This 1 Element Keep Vaxart in the Coronavirus Vaccine Race?

TheMotleyFool

0 0

Can This 1 Element Keep Vaxart in the Coronavirus Vaccine Race?

Vaxart's (NASDAQ: VXRT) shares plunged 58% in one trading session after one point in a clinical trial of its coronavirus vaccine candidate disappointed investors. In this Motley Fool Live video recorded on Feb. 26, 2021, healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Adria Cimino discuss the negatives and positives of the trial report -- and what they mean for the future of Vaxart's coronavirus vaccine program.

Source Fool.com

Like: 0

VXRT

Share